Clinical Trials in Tennessee

Showing 8761-8780 of 15,329 trials

Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants

NCT01778634

The purpose of this study is to determine whether intravenous azithromycin is effective in eradicating Ureaplasma respiratory tract infection in preterm infants born at 24 to 28 weeks gestation.

Ureaplasma Infections

University of Maryland, Baltimore121 participantsStarted Jul 2013

Birmingham, Alabama, United States • Newark, Delaware, United States • Baltimore, Maryland, United States +4 more locations

COMPLETEDPhase 229 miles

Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT01412229

This is a non-randomized, open-label phase II trial of 40 patients with poor prognosis head and neck cancer, defined as surgically unresectable and/or ≥N2b disease and judged appropriate for non-surgical definitive therapy.

Head and Neck Cancer

UNC Lineberger Comprehensive Cancer Center40 participantsStarted Feb 2012

Chapel Hill, North Carolina, United States • Nashville, Tennessee, United States • Seattle, Washington, United States

TERMINATED29 miles

Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation

NCT03553550

The purpose of this research study is to learn more about changes in cell-free tumor DNA in blood samples, also known as a liquid biopsy, as they relate to treatment and response to treatment.

Non Small Cell Lung Cancer

Addario Lung Cancer Medical Institute38 participantsStarted Jun 2018

Atlanta, Georgia, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +3 more locations

Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants

Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation

Find Trials by Condition in Tennessee

Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies

Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Phase I Trial of Measles Vectored Chikungungya Vaccine

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes

Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A

An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures

Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma

A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL

Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo